Acute Myelogenous Leukemia Genetics, Biology and Therapy /
Acute myelogenous leukemia (AML), is the most common form of leukemia in adults. AML is a deadly form of malignancy, the prognosis for which has not improved in the last two decades. More importantly, it is a malignancy that is seen in older adults, therefore the number of cases is likely to rise as...
Συγγραφή απο Οργανισμό/Αρχή: | |
---|---|
Άλλοι συγγραφείς: | |
Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
Γλώσσα: | English |
Έκδοση: |
New York, NY :
Springer New York,
2010.
|
Έκδοση: | 1. |
Σειρά: | Cancer Treatment and Research,
145 |
Θέματα: | |
Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- The Leukemia Stem Cell
- Epigenetic Mechanisms in AML – A Target for Therapy
- Chromosomal Translocations in AML: Detection and Prognostic Significance
- Chromosomal Deletions in AML
- Genes Predictive of Outcome and Novel Molecular Classification Schemes in Adult Acute Myeloid Leukemia
- Receptor Tyrosine Kinase Alterations in AML – Biology and Therapy
- Lineage-Specific Transcription Factor Aberrations in AML
- Proleukemic RUNX1 and CBF? Mutations in the Pathogenesis of Acute Leukemia
- Acute Myeloid Leukemia with Mutated Nucleophosmin (NPM1): Molecular, Pathological, and Clinical Features
- MicroRNAs: New Players in AML Pathogenesis
- Murine Models of Human Acute Myeloid Leukemia
- Apoptosis in Leukemias: Regulation and Therapeutic Targeting
- Acute Promyelocytic Leukemia: A Paradigm for Differentiation Therapy
- Immunotherapy of AML
- Therapy of Acute Myelogenous Leukemia in Adults.